Redemption of Diminishing Returns at HOOK in the financial interval closing December 31 2022

For the financial interval closing December 31 2022 company decreased a loss per share of $-0.11 per share compare to $-0.68 a year before and EPS improved from $-0.25 per share from the prior quarter.

Revenues grew sharply by 109.922 % to $7.83 millions from $3.73 millions in the similar quarter a year before and sequentially Revenue doubled by 251.031 % from $2.23 millions.




In the financial interval closing December 31 2022 Hookipa Pharma Inc reported net deficit of $-12.311 million, instead of deficit of $-27.685 millions in the similar quarter a year ago.

What's more important, the HOOK claimed as well a shortfall of $-64.92 millions and for the financial 12 Months 2022, Revenues of $14.25 millions.

Major Pharmaceutical Preparations The Major Pharmaceutical Preparations company has decreased it's deficit per share to $-0.99 from $-2.30 in the prior fiscal year, while Revenues fell by -22.76 % from $18.45 millions a year before.

Hookipa Pharma Inc is expected to report next financial earnings on May 01, 2023.

Hookipa Pharma Inc's Asset Turnover

Hookipa Pharma Inc's ROI

Other HOOK's Earnings Reports

A loss of $-0.25 per Share at the company during the fiscal interval closing September 30 2022